{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:16:44Z","timestamp":1789989404829,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier","isbn-type":[{"value":"9780128122136","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.mie.2016.10.013","type":"book-chapter","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T16:17:03Z","timestamp":1480609023000},"page":"157-183","source":"Crossref","is-referenced-by-count":6,"title":["Analyzing Amyloid-\u03b2 Peptide Modulation Profiles and Binding Sites of \u03b3-Secretase Modulators"],"prefix":"10.1016","author":[{"given":"J.","family":"Trambauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fukumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kretner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.mie.2016.10.013_bb0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/mp.2015.74","article-title":"Amyloid-PET predicts inhibition of de novo plaque formation upon chronic \u03b3-secretase modulator treatment","volume":"20","author":"Brendel","year":"2015","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0010","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00001756-199805110-00043","article-title":"Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and Notch signaling","volume":"9","author":"Brockhaus","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/bs.mie.2016.10.013_bb0015","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1021\/acs.jmedchem.5b01960","article-title":"Gamma secretase modulators: New Alzheimer's drugs on the horizon?","volume":"59","author":"Bursavich","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0020","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1046\/j.1471-4159.1997.69062432.x","article-title":"Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation","volume":"69","author":"Capell","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0025","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the \u03b2-amyloid precursor protein in familial Alzheimer's disease increases \u03b2-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.1016\/bs.mie.2016.10.013_bb0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cn200098p","article-title":"Piperidine acetic acid based \u03b3-secretase modulators directly bind to Presenilin-1","volume":"2","author":"Crump","year":"2011","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.mie.2016.10.013_bb0035","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1021\/bi400377p","article-title":"Development and mechanism of \u03b3-secretase modulators for Alzheimer's disease","volume":"52","author":"Crump","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0040","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1471-4159.2007.04467.x","article-title":"Cholesterol independent effect of LXR agonist TO-901317 on \u03b3-secretase","volume":"101","author":"Czech","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0045","doi-asserted-by":"crossref","first-page":"24504","DOI":"10.1074\/jbc.M700618200","article-title":"Insensitivity to A\u03b242-lowering non-steroidal anti-inflammatory drugs (NSAIDs) and \u03b3-secretase inhibitors is common among aggressive presenilin-1 mutations","volume":"282","author":"Czirr","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-pharmtox-010814-124309","article-title":"Learning by failing: Ideas and concepts to tackle \u03b3-secretases in Alzheimer's disease and beyond","volume":"55","author":"De Strooper","year":"2015","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.mie.2016.10.013_bb0055","doi-asserted-by":"crossref","first-page":"a006304","DOI":"10.1101\/cshperspect.a006304","article-title":"Presenilins and \u03b3-secretase: Structure, function, and role in Alzheimer disease","volume":"2","author":"De Strooper","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/bs.mie.2016.10.013_bb0060","doi-asserted-by":"crossref","first-page":"37181","DOI":"10.1074\/jbc.C111.276972","article-title":"Novel \u03b3-secretase enzyme modulators directly target presenilin protein","volume":"286","author":"Ebke","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0065","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/cn3000857","article-title":"Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa","volume":"3","author":"Findeis","year":"2012","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.mie.2016.10.013_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-2011-101065","article-title":"The many substrates of presenilin\/\u03b3-secretase","volume":"25","author":"Haapasalo","year":"2011","journal-title":"Journal of Alzheimer's Disease: JAD"},{"key":"10.1016\/bs.mie.2016.10.013_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030484","article-title":"Presenilin is the molecular target of acidic \u03b3-secretase modulators in living cells","volume":"7","author":"Jumpertz","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/bs.mie.2016.10.013_bb0080","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1096\/fj.12-225649","article-title":"Steroids as \u03b3-secretase modulators","volume":"27","author":"Jung","year":"2013","journal-title":"FASEB Journal"},{"key":"10.1016\/bs.mie.2016.10.013_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: Unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/bs.mie.2016.10.013_bb0090","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neuron.2010.08.018","article-title":"Modulation of \u03b3-secretase reduces \u03b2-amyloid deposition in a transgenic mouse model of Alzheimer's disease","volume":"67","author":"Kounnas","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/bs.mie.2016.10.013_bb0095","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1074\/jbc.M110.213587","article-title":"Attenuated A\u03b242 responses to low potency \u03b3-secretase modulators can be overcome for many pathogenic presenilin mutants by second-generation compounds","volume":"286","author":"Kretner","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0100","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15252\/emmm.201505952","article-title":"Generation and deposition of A\u03b243 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease","volume":"8","author":"Kretner","year":"2016","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/bs.mie.2016.10.013_bb0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1471-4159.2011.07248.x","article-title":"Regulated intramembrane proteolysis\u2014Lessons from amyloid precursor protein processing","volume":"117","author":"Lichtenthaler","year":"2011","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphys.2014.00463","article-title":"Molecular mechanism of the intramembrane cleavage of the \u03b2-carboxyl terminal fragment of amyloid precursor protein by \u03b3-secretase","volume":"5","author":"Morishima-Kawashima","year":"2014","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/bs.mie.2016.10.013_bb0115","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.bmcl.2007.07.044","article-title":"Conversion of the LXR-agonist TO-901317\u2014From inverse to normal modulation of \u03b3-secretase by addition of a carboxylic acid and a lipophilic anchor","volume":"17","author":"Narlawar","year":"2007","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/bs.mie.2016.10.013_bb0120","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1038\/emboj.2011.372","article-title":"Phenylpiperidine-type \u03b3-secretase modulators target the transmembrane domain 1 of presenilin 1","volume":"30","author":"Ohki","year":"2011","journal-title":"EMBO Journal"},{"key":"10.1016\/bs.mie.2016.10.013_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.celrep.2012.11.028","article-title":"\u03b3-Secretase modulators and presenilin 1 mutants act differently on presenilin\/\u03b3-secretase function to cleave A\u03b242 and A\u03b243","volume":"3","author":"Okochi","year":"2013","journal-title":"Cell Reports"},{"key":"10.1016\/bs.mie.2016.10.013_bb0130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.M708754200","article-title":"Generation of A\u03b238 and A\u03b242 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and \u03b3-secretase modulation","volume":"283","author":"Page","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0135","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1074\/jbc.M112.398602","article-title":"\u03b3-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin","volume":"288","author":"Pozdnyakov","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","article-title":"Longer forms of amyloid \u03b2 protein: Implications for the mechanism of intramembrane cleavage by \u03b3-secretase","volume":"25","author":"Qi-Takahara","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.mie.2016.10.013_bb0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/bs.mie.2016.10.013_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2007.04.011","article-title":"Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different \u03b3-secretase complexes","volume":"27","author":"Shirotani","year":"2007","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.mie.2016.10.013_bb0155","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1074\/jbc.274.12.7615","article-title":"The biological and pathological function of the presenilin-1 \u0394exon 9 mutation is independent of its defect to undergo proteolytic processing","volume":"274","author":"Steiner","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0160","doi-asserted-by":"crossref","first-page":"39062","DOI":"10.1074\/jbc.C200469200","article-title":"PEN-2 is an integral component of the \u03b3-secretase complex required for coordinated expression of presenilin and nicastrin","volume":"277","author":"Steiner","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1097-2765(00)00061-7","article-title":"Requirements for presenilin-dependent cleavage of Notch and other transmembrane proteins","volume":"6","author":"Struhl","year":"2000","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.mie.2016.10.013_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sbi.2015.12.008","article-title":"Structural biology of intramembrane proteases: Mechanistic insights from rhomboid and S2P to \u03b3-secretase","volume":"37","author":"Sun","year":"2016","journal-title":"Current Opinion in Structural Biology"},{"key":"10.1016\/bs.mie.2016.10.013_bb0175","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1084\/jem.20150892","article-title":"Qualitative changes in human \u03b3-secretase underlie familial Alzheimer's disease","volume":"212","author":"Szaruga","year":"2015","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/bs.mie.2016.10.013_bb0180","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","article-title":"\u03b3-Secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of \u03b2-carboxyl terminal fragment","volume":"29","author":"Takami","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.mie.2016.10.013_bb0185","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1073\/pnas.1402171111","article-title":"Allosteric regulation of \u03b3-secretase activity by a phenylimidazole-type \u03b3-secretase modulator","volume":"111","author":"Takeo","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mie.2016.10.013_bb0190","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1073\/pnas.94.5.2025","article-title":"The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid \u03b2 protein ending at the 42nd (or 43rd) residue","volume":"94","author":"Tomita","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mie.2016.10.013_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt107","article-title":"Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease","volume":"4","author":"Weggen","year":"2012","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/bs.mie.2016.10.013_bb0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/bs.mie.2016.10.013_bb0205","doi-asserted-by":"crossref","first-page":"30748","DOI":"10.1074\/jbc.M304824200","article-title":"A\u03b242-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain","volume":"278","author":"Weggen","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0210","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/bi801204g","article-title":"Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human \u03b3-secretase","volume":"48","author":"Winkler","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/bs.mie.2016.10.013_bb0215","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1523\/JNEUROSCI.5354-05.2006","article-title":"The GxGD motif of presenilin contributes to catalytic function and substrate identification of \u03b3-secretase","volume":"26","author":"Yamasaki","year":"2006","journal-title":"Journal of Neuroscience"}],"container-title":["Methods in Enzymology","Enzymology at the Membrane Interface: Intramembrane Proteases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687916303767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687916303767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T04:55:21Z","timestamp":1568609721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687916303767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128122136"],"references-count":43,"URL":"https:\/\/doi.org\/10.1016\/bs.mie.2016.10.013","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}